Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Accelerated partial breast irradiation in the elderly: 5-year results of high-dose rate multi-catheter brachytherapy

    To evaluate clinical outcome after accelerated partial breast irradiation (APBI) in the elderly after high-dose-rate interstitial multi-catheter brachytherapy (HIBT).

    Caroline Genebes, Marie-Eve Chand, Jocelyn Gal, Mathieu Gautier in Radiation Oncology (2014)

  2. Article

    Open Access

    High-dose rate brachytherapy in localized penile cancer: short-term clinical outcome analysis

    To assess clinical outcomes of high-dose rate interstitial brachytherapy (HIB) in localized penile carcinoma.

    Yohann Rouscoff, Alexander Tuan Falk, Matthieu Durand, Jocelyn Gal in Radiation Oncology (2014)

  3. Article

    Open Access

    Protocol of the “As du Coeur” study: a randomized controlled trial on physical activity maintenance in cardiovascular patients

    Although the benefits of supervised physical activity programs in cardiac rehabilitation have been well documented, the amount of physical activity often drops quickly after the end of the supervised period. T...

    Marion Fournier, Rémi Radel, Karim Tifratene in BMC Cardiovascular Disorders (2016)

  4. Article

    Multicenter prospective micro-costing study evaluating mandibular free-flap reconstruction

    Free-flap mandibular reconstruction is a highly specialized procedure associated with severe complications necessitating re-interventions and re-hospitalizations. This surgery is expensive in terms of health w...

    Olivier Dassonville, Alexandre Bozec in European Archives of Oto-Rhino-Laryngology (2017)

  5. Article

    Open Access

    CXCL7 is a predictive marker of sunitinib efficacy in clear cell renal cell carcinomas

    Sunitinib is one of the first-line standard treatments for metastatic clear cell renal cell carcinoma (ccRCC) with a median time to progression shorter than 1 year. The objective is to discover predictive mark...

    Maeva Dufies, Sandy Giuliano, Julien Viotti in British Journal of Cancer (2017)

  6. Article

    Open Access

    “As du Coeur” study: a randomized controlled trial on physical activity maintenance in cardiovascular patients

    The benefits of supervised physical activity programs in cardiac rehabilitation have been amply demonstrated, but the quantity of physical activity often declines quickly once supervision ends. This trial asse...

    Marion Fournier, Rémi Radel, Laurent Bailly in BMC Cardiovascular Disorders (2018)

  7. Article

    Open Access

    Single fraction of accelerated partial breast irradiation in the elderly: early clinical outcome

    To analyze the clinical outcome of elderly women with early breast cancer who underwent accelerated partial breast irradiation (APBI) based on a post-operative single fraction of multicatheter interstitial hig...

    Rémy Kinj, Marie-Eve Chand, Jocelyn Gal, Mathieu Gautier in Radiation Oncology (2018)

  8. Article

    Open Access

    “As du Coeur” study: a randomized controlled trial on quality of life impact and cost effectiveness of a physical activity program in patients with cardiovascular disease

    Physical activity programs (PAP) in patients with cardiovascular disease require evidence of cost-utility. To assess improvement in health-related quality of life (QoL) and reduction of health care consumption...

    Laurent Bailly, Philippe Mossé, Stéphane Diagana in BMC Cardiovascular Disorders (2018)

  9. No Access

    Article

    18F-DOPA PET/CT in brain tumors: impact on multidisciplinary brain tumor board decisions

    This study aimed to assess the therapeutic impact and diagnostic accuracy of 18F-DOPA PET/CT in patients with glioblastoma or brain metastases.

    Olivier Humbert, Véronique Bourg in European Journal of Nuclear Medicine and M… (2019)

  10. Article

    Open Access

    Long term efficacy and toxicity after stereotactic ablative reirradiation in locally relapsed stage III non-small cell lung cancer

    In stage III non-small cell lung cancer (NSCLC) treated with concomitant chemoradiotherapy, there is a high rate of relapse. Some of these relapses are only local and can be treated by stereotactic ablative ra...

    Shakeel Sumodhee, Pierre-Yves Bondiau, Michel Poudenx, Charlotte Cohen in BMC Cancer (2019)

  11. Article

    Correction to: 18F-DOPA PET/CT in brain tumors: impact on multidisciplinary brain tumor board decisions

    Jérôme Barriere was inadvertently missing in the original version of this article. He has participated to the study design, protocol writing and inclusion of a significant number of patients.

    Olivier Humbert, Véronique Bourg in European Journal of Nuclear Medicine and M… (2019)

  12. No Access

    Article

    GEC-ESTRO APBI classification as a decision-making tool for the management of 2nd ipsilateral breast tumor event

    Second ipsilateral breast tumor event (2ndIBTE) occurring after primary radio-surgical treatment can be treated by either salvage mastectomy or 2nd conservative treatment (2ndCT) including an accelerated parti...

    Lucile Montagne, Jocelyn Gal, Marie-Eve Chand in Breast Cancer Research and Treatment (2019)

  13. No Access

    Article

    Evaluation of the information given to patients undergoing total pharyngolaryngectomy and quality of life: a prospective multicentric study

    Providing cancer patients with adequate information is essential to their confidence and satisfaction regarding medical care. The aims of this study were to evaluate the information given to patients undergoin...

    Alexandre Bozec, Philippe Schultz in European Archives of Oto-Rhino-Laryngology (2019)

  14. Article

    Open Access

    Five-year oncological outcome after a single fraction of accelerated partial breast irradiation in the elderly

    To update the clinical outcome of an elderly women cohort with early breast cancer who underwent accelerated partial breast irradiation (APBI) based on a post-operative single fraction of multicatheter interst...

    Rémy Kinj, Marie-Eve Chand, Jocelyn Gal, Mathieu Gautier in Radiation Oncology (2019)

  15. No Access

    Article

    Germinal Immunogenetics predict treatment outcome for PD-1/PD-L1 checkpoint inhibitors

    Background Checkpoint inhibitors bring marked benefits but only in a minority of patients and may also be associated with severe adverse events. Treatment outcome still cannot be faithfully predicted. The followi...

    Sadal Refae, Jocelyn Gal, Nathalie Ebran, Josiane Otto in Investigational New Drugs (2020)

  16. Article

    Open Access

    Hyperprogression under Immune Checkpoint Inhibitor: a potential role for germinal immunogenetics

    Hyperprogressive disease (HPD), an unexpected acceleration of tumor growth kinetics, is described in cancer patients treated with anti-PD-1/anti-PD-L1 agents. Here, our aim was to take into consideration the h...

    Sadal Refae, Jocelyn Gal, Patrick Brest, Damien Giacchero in Scientific Reports (2020)

  17. Article

    Open Access

    Comment on: “Exploring the best treatment options for BRAF-mutant metastatic colon cancer”

    Gérard Milano, Jocelyn Gal in British Journal of Cancer (2020)

  18. Article

    Open Access

    Author Correction: Hyperprogression under Immune Checkpoint Inhibitor: a potential role for germinal immunogenetics

    An amendment to this paper has been published and can be accessed via a link at the top of the paper.

    Sadal Refae, Jocelyn Gal, Patrick Brest, Damien Giacchero in Scientific Reports (2020)

  19. Article

    Correction to: Germinal Immunogenetics predict treatment outcome for PD-1/PD-L1 checkpoint inhibitors

    Corrections are needed to the original version of this article.

    Sadal Refae, Jocelyn Gal, Nathalie Ebran, Josiane Otto in Investigational New Drugs (2021)

  20. No Access

    Article

    Correlations between long-term quality of life and patient needs and concerns following head and neck cancer treatment and the impact of psychological distress. A multicentric cross-sectional study

    To assess patient needs and concerns after head and neck squamous cell carcinoma (HNSCC) treatment and their possible correlations with long-term quality of life (QoL) and to examine the potential impact of ps...

    Roxane Elaldi, Lise-Marie Roussel in European Archives of Oto-Rhino-Laryngology (2021)

previous disabled Page of 2